Portfolio company
Pleo Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops oral treatments to mitigate cannabis withdrawal symptoms for adult patients with cannabis use disorder.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sobrera Pharma
This pharmaceutical company develops medical treatments for patients suffering from alcohol use disorder and other addiction-related conditions.
Amygdala Neurosciences
This biopharmaceutical company develops oral enzyme inhibitors to treat substance use disorders by reducing cravings and preventing relapse in patients.
Newleos Therapeutics
The company develops oral small-molecule drugs to treat neuropsychiatric disorders, including anxiety and substance use disorders, for patients seeking therapies with fewer side effects.
Aelis Farma
The company develops pharmacological treatments for brain diseases including cannabis use disorders and cognitive deficits for patients with unmet medical needs.
Opiant
This company develops pharmacological treatments for substance use, addictive and eating disorders for patients and healthcare providers.
Orexo AB
This pharmaceutical company develops improved medications and digital therapies for patients with opioid use disorder, cancer pain and insomnia.
Mycrodose Therapeutics
This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.
Melius Pharma
The company develops pharmaceutical treatments for chronic cough in patients with idiopathic pulmonary fibrosis.